enteric coated aspirin regular strength

Generic: aspirin

Labeler: safeway
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name enteric coated aspirin regular strength
Generic Name aspirin
Labeler safeway
Dosage Form TABLET, DELAYED RELEASE
Routes
ORAL
Active Ingredients

aspirin 325 mg/1

Manufacturer
Safeway

Identifiers & Regulatory

Product NDC 21130-081
Product ID 21130-081_27d89a75-79e6-3b34-e063-6394a90a7d7d
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2026-12-31
Marketing Start 2015-08-05

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 21130081
Hyphenated Format 21130-081

Supplemental Identifiers

RxCUI
198467
UNII
R16CO5Y76E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name enteric coated aspirin regular strength (source: ndc)
Generic Name aspirin (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 325 mg/1
source: ndc
Packaging
  • 500 TABLET, DELAYED RELEASE in 1 BOTTLE (21130-081-05)
source: ndc

Packages (1)

21130-081-05 500 TABLET, DELAYED RELEASE in 1 BOTTLE (21130-081-05)

Ingredients (1)

aspirin (325 mg/1)

Linked Drug Pages (1)

Enteric Coated Aspirin Regular Strength ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "27d89a75-79e6-3b34-e063-6394a90a7d7d", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "unii": ["R16CO5Y76E"], "rxcui": ["198467"], "spl_set_id": ["96359eb6-62bc-4b13-960c-050af99a8c02"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Safeway"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, DELAYED RELEASE in 1 BOTTLE (21130-081-05)", "package_ndc": "21130-081-05", "marketing_start_date": "20150805"}], "brand_name": "Enteric Coated Aspirin Regular Strength", "product_id": "21130-081_27d89a75-79e6-3b34-e063-6394a90a7d7d", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "21130-081", "generic_name": "Aspirin", "labeler_name": "Safeway", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Enteric Coated Aspirin", "brand_name_suffix": "Regular Strength", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20150805", "listing_expiration_date": "20261231"}